Form 4: RETRACTABLE TECHNOLOGIES CEO Plans Future Stock Purchase

Retractable Technologies CEO Thomas J. Shaw plans to acquire 49,541 shares of common stock in August 2025 under a pre-arranged 10b5-1 plan.

Summary

• Thomas J. Shaw, the President and CEO, Director, and 10% Owner of Retractable Technologies Inc. (RVP), reported a planned acquisition of company common stock.
• The transaction involves the purchase of 49,541 shares of common stock at a weighted average price of $0.747 per share.
• This acquisition is scheduled to occur on August 7, 2025.
• The purchase is being made pursuant to a Rule 10b5-1(c) plan, which was adopted on August 22, 2024.
• Following this planned transaction, Mr. Shaw will directly own 15,578,754 shares of common stock.
• Additionally, Mr. Shaw indirectly controls 831,600 shares, with investment power over 500,000 shares as Trustee for a family member and voting control over the remainder via a voting agreement.

Sentiment

Score: 8

Explanation: The sentiment is positive due to significant insider buying by the CEO and a 10% owner, indicating strong confidence in the company's valuation and future prospects, even though it's a pre-planned transaction.

Positives

• The planned acquisition by the President and CEO, a Director, and 10% owner, signals strong insider confidence in the company's future prospects.
• Purchasing shares at $0.747 suggests management believes the stock is undervalued at current levels.

Future Outlook

NA

Industry Context

This insider transaction reflects a specific corporate action by a key executive within the medical device industry. While not directly indicative of broader industry trends, insider buying can signal confidence in the company's position or future performance within its sector.

Related Party Transactions

• Mr. Shaw has indirect beneficial ownership of 831,600 shares, including 500,000 shares over which he has investment power as Trustee for the benefit of a family member, and voting control over the remainder through a voting agreement.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing investor confidence and demand for the stock.
• Employees may perceive this as a sign of stability and positive outlook from leadership.

Key Dates

Recommendation

The planned purchase of shares by the President and CEO, who is also a Director and 10% owner, at a price of $0.747, suggests strong insider conviction that the company's stock is undervalued or poised for future growth. While executed under a 10b5-1 plan, the decision to set up such a plan for a future purchase at this price point indicates a long-term bullish outlook from a key insider. This insider buying activity typically serves as a positive indicator for investors.

Keywords

Retractable Technologies, RVP, Insider Buying, CEO Stock Purchase, 10b5-1 Plan, Medical Devices, Healthcare, Equity Acquisition